225430.KS · 케이엠제약

South Korea · RS rating 9 · As of 2026-10-14

Price698.00 KRW
1-day change+0.0%
RS rating (overall / 1M / 3M / 12M)9 / 88 / 3 / 2
StageBasing
Composite / Minervini / CANSLIM score27 / 23 / 31
Industry group (rank)Finance-Investment Mgmt (56)
EPS growth Q/Q+9.3%
Sales growth Q/Q-14.1%
Distance from 52-week high+86.8%
Market cap (USD)$2.9M
Open South Korea in the interactive screener